Quarterly Activity Report and Appendix 4C for 31 Mar 2022

Imagion has released the Quarterly Activity Report and AImagion Biosystems Quarterly Activity Report – quarter ending 31 March 2022ppendix 4C for the period ending on 31 March 2022.

The announcement highlights:

  • MagSense® HER2 breast cancer study interim results released during the quarter
  • Move to new R&D facility completed
  • Sponsored Research Agreement executed with researchers at Massachusetts
    General Hospital

Read the full announcements here: Quarterly Activity Report and Appendix 4C